B
9.30
0.22 (2.42%)
| 前收盘价格 | 9.08 |
| 收盘价格 | 9.44 |
| 成交量 | 192,617 |
| 平均成交量 (3个月) | 339,637 |
| 市值 | 644,061,312 |
| 价格/销量 (P/S) | 12.19 |
| 股市价格/股市净资产 (P/B) | 0.640 |
| 52周波幅 | |
| 利润日期 | 4 Aug 2025 - 8 Aug 2025 |
| 营业利益率 (TTM) | -1,824.78% |
| 稀释每股收益 (EPS TTM) | -2.90 |
| 季度收入增长率 (YOY) | -30.40% |
| 总债务/股东权益 (D/E MRQ) | 1.20% |
| 流动比率 (MRQ) | 13.81 |
| 营业现金流 (OCF TTM) | -164.72 M |
| 杠杆自由现金流 (LFCF TTM) | -104.81 M |
| 资产报酬率 (ROA TTM) | -16.90% |
| 股东权益报酬率 (ROE TTM) | -29.04% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看跌 |
| Biotechnology (全球的) | 混合的 | 看跌 | |
| 股票 | Bicycle Therapeutics plc | 看跌 | 看跌 |
AIStockmoo 评分
1.1
| 分析师共识 | 2.0 |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.0 |
| 平均 | 1.13 |
|
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 内部持股比例 | 1.73% |
| 机构持股比例 | 92.11% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Baker Bros. Advisors Lp | 31 Dec 2024 | 10,885,357 |
| Point72 Asset Management, L.P. | 31 Dec 2024 | 4,554,900 |
| Fcpm Iii Services B.V. | 31 Dec 2024 | 3,452,330 |
| Westfield Capital Management Co Lp | 31 Dec 2024 | 2,610,337 |
| Armistice Capital, Llc | 31 Dec 2024 | 2,196,000 |
| Siren, L.L.C. | 31 Dec 2024 | 1,839,398 |
| Deep Track Capital, Lp | 31 Dec 2024 | 1,276,081 |
| Tybourne Capital Management (Hk) Ltd | 31 Dec 2024 | 1,269,535 |
| Ra Capital Management, L.P. | 31 Dec 2024 | 1,093,477 |
| Candriam S.C.A. | 31 Dec 2024 | 1,087,876 |
| Ecor1 Capital, Llc | 31 Dec 2024 | 910,000 |
| Principal Financial Group Inc | 31 Mar 2025 | 631,260 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 33.00 (HC Wainwright & Co., 254.84%) | 购买 |
| 中 | 26.00 (179.57%) | |
| 低 | 14.00 (B. Riley Securities, 50.54%) | 保留 |
| 平均值 | 24.43 (162.69%) | |
| 总计 | 6 购买, 1 保留 | |
| 平均价格@调整类型 | 9.85 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| B. Riley Securities | 02 May 2025 | 14.00 (50.54%) | 保留 | 9.30 |
| JMP Securities | 02 May 2025 | 22.00 (136.56%) | 购买 | 9.30 |
| Needham | 02 May 2025 | 29.00 (211.83%) | 购买 | 9.30 |
| 09 Apr 2025 | 30.00 (222.58%) | 购买 | 6.88 | |
| RBC Capital | 02 May 2025 | 32.00 (244.09%) | 购买 | 9.30 |
| Barclays | 01 May 2025 | 15.00 (61.29%) | 购买 | 9.08 |
| Citizens Capital Markets | 26 Feb 2025 | 26.00 (179.57%) | 购买 | 11.32 |
| HC Wainwright & Co. | 26 Feb 2025 | 33.00 (254.84%) | 购买 | 11.32 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合